Vicks VapoDrops

Manufacturer: The Procter & Gamble Manufacturing Company
Effective date: 2023-10-17
Label type: HUMAN OTC DRUG LABEL
Version: 10
Source: legacy-cache
Hydrated at: 2026-08-01 21:24:07

Label at a glance#

ProductVicks VapoDrops Cough Relief

Active ingredientMENTHOL

Label structure11 sections

Indications and uses

temporarily relieves cough due to a cold or inhaled irritants minor sore throat

Dosage and administration

adults & children 5 yrs. & older dissolve 2 drops (one at a time) slowly in the mouth children 2 to under 5 yrs. ask a doctor children under 2 yrs. do not use Repeat every 2 hours as needed or as directed by a doctor.

Storage and handling

store at room temperature

Contacts and useful links#

PhoneLabel contact1-800-707-1709

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (per drop)

OTC - ACTIVE INGREDIENT SECTION

Menthol 3.3 mg

Purpose

OTC - PURPOSE SECTION

Cough suppressant/oral anesthetic

Uses

INDICATIONS & USAGE SECTION

temporarily relieves

cough due to a cold or inhaled irritants
minor sore throat

Warnings

WARNINGS SECTION

Sore Throat Warning-

SPL UNCLASSIFIED SECTION

Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult doctor promptly. Do not use more than 2 days or administer to children under 5 years of age unless directed by doctor.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

cough accompanied by excessive phlegm (mucus)
persistent or chronic cough such as occurs with smoking, asthma, or emphysema
a severe sore throat accompanied by difficulty in breathing or that lasts more than 2 days

Stop use and ask a doctor if

OTC - STOP USE SECTION

cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
sore mouth symptoms do not improve in 7 days, or if irritation, pain, or redness persists or worsens.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

adults & children 5 yrs. & older	dissolve 2 drops (one at a time) slowly in the mouth
children 2 to under 5 yrs.	ask a doctor
children under 2 yrs.	do not use

Repeat every 2 hours as needed or as directed by a doctor.

Other information

STORAGE AND HANDLING SECTION

store at room temperature

Inactive ingredients

INACTIVE INGREDIENT SECTION

ascorbic acid, caramel, eucalyptus oil, liquid glucose, sucrose

Questions?

OTC - QUESTIONS SECTION

1-800-707-1709

SPL UNCLASSIFIED SECTION

Made in Mexico by
Procter & Gamble

Dist. by Procter & Gamble,
Cincinnati OH 45202

PRINCIPAL DISPLAY PANEL - 20 Drops

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

VICKS^®

VapoDrops™

Menthol Cough Suppressant/Oral Anesthetic

COUGH RELIEF

MENTHOL FLAVOR

See Drug Facts

20 Drops

680

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
37000-680-20	2021-02-12	C162847	48780-1	ba0f9c33-5b47-a910-e053-dadaa90a0b85	Vicks ® VapoDrops™ Cough Relief
37000-680-20	2021-01-29	C162847	48780-1	ba0f9c33-5b47-a910-e053-dadaa90a0b85	Vicks ® VapoDrops™ Cough Relief

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Menthol	ACTIVE INGREDIENT	L7T10EIP3A	1
Menthol	ACTIVE MOIETY	L7T10EIP3A	1
ascorbic acid	INACTIVE INGREDIENT	PQ6CK8PD0R	1
caramel	INACTIVE INGREDIENT	T9D99G2B1R	1
eucalyptus oil	INACTIVE INGREDIENT	2R04ONI662	1
sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

Vicks VapoDrops Cough Relief
Menthol
ASCORBIC ACID
CARAMEL
EUCALYPTUS OIL
SUCROSE
ANHYDROUS DEXTROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
37000-680	37000-680-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ASCORBIC ACID	PQ6CK8PD0R	IACT
CARAMEL	T9D99G2B1R	IACT
EUCALYPTUS OIL	2R04ONI662	IACT
SUCROSE	C151H8M554	IACT
ANHYDROUS DEXTROSE	5SL0G7R0OK	IACT
MENTHOL	L7T10EIP3A	ACTIB

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 83 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	GRANULE, FOR SUSPENSION / ORAL	2.5 mg/5ml		Exact identifier — unii candidate 9 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	AEROSOL, SPRAY / RESPIRATORY (INHALATION)	0.11 %w/w		Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	SUSPENSION / ORAL	111.12 mg/5ml		Exact identifier — unii candidate 9 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION / INTRAVENOUS		1440 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	CREAM / TOPICAL	0.26 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	TABLET / ORAL		80 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	POWDER, FOR SOLUTION / ORAL		560 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	LOTION / TOPICAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	GEL / TOPICAL		7 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION / INTRACAVITARY	5 mg		Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	SOLUTION / ORAL		600 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	TABLET, ORALLY DISINTEGRATING / ORAL	2.35 mg		Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	LIQUID / ORAL	5.3 mg		Exact identifier — unii candidate 9 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	SYRUP / ORAL		200 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	SOLUTION / ORAL		11 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		1440 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	CONCENTRATE / ORAL	6 mg/1ml		Exact identifier — unii candidate 25 equally ranked IID candidates
caramel	CARAMEL	T9D99G2B1R	CAPSULE / ORAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	SOLUTION / RESPIRATORY (INHALATION)	0.04 %w/w		Exact identifier — unii candidate 25 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION, SOLUTION / INTRAVENOUS		4 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION, SOLUTION / INFILTRATION	0.2 %w/v		Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
eucalyptus oil	EUCALYPTUS OIL	2R04ONI662	SYRUP / ORAL	NA		Exact identifier — unii candidate
sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	SUSPENSION / ORAL		520 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	TABLET, FILM COATED / ORAL	20 mg		Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	CAPSULE, EXTENDED RELEASE / ORAL		17 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	AEROSOL, METERED / RESPIRATORY (INHALATION)	0.1 %w/w		Exact identifier — unii candidate 25 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
07e9cf29-1386-c4a1-e063-6394a90a347c			f4f15755-b8e5-4a5d-9df4-1ccf27a08ac9	2023-10-17	Warnings	Exact identifier spl id: 07e9cf29-1386-c4a1-e063-6394a90a347c spl set id: f4f15755-b8e5-4a5d-9df4-1ccf27a08ac9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.